Executive Vice Chairman of the Board
Executive Vice Chairman of the Board since 2016, Member of the Board since 1999. CEO of Oasmia and one of the founders of the company. Has extensive experience in coordination of research projects and strategic development of global intangible assets. Also Chairman of the Board in Qdoxx Pharma AB and Oasmia Animal Health AB.
Chief Executive Officer
Mikael has a Master of Science in Chemical Engineering and has 25 years of experience from several companies within international pharmaceutical industry in research and development, production, quality assurance and as Qualified Person (QP).
Chief Operating Officer
Has been employed by Oasmia since 2005 and appointed to COO in 2016. He has 20 years' experience from logistics and purchasing and has previously worked at Meda and Pharmalink among others. At Oasmia, Amir has worked as production manager and head of logistics and purchases. He is also the current CEO of the subsidiary Qdoxx.
Chief Financial Officer
Fredrik Gynnerstedt possesses 15 years' experience in international business administration and activities. Previously, Fredrik was employed as the Director of Collaboration at Karnov Group. Prior to that role, he served as Chief Financial Officer for publicly held Bringwell AB, and as auditor and consultant at Ernst & Young. Fredrik has a Master's degree in Business Administration from Stockholm University.
Executive Vice President
Employed since 2014. Anders has more than 15 years of experience from international strategic business development and finance at Q-Med and Pharmacia. He has a Master of Business Administration degree from Uppsala University. Anders' last employment was as CEO of Nexttobe AB.